期刊文献+

联合位点突变的乙肝病毒核心启动子转染L-02及对细胞增殖能力的影响 被引量:1

Transfection of L-02 with combo mutant core promoter and its effect on cell proliferation ability
原文传递
导出
摘要 目的通过基因合成A1762T/G1764A/T1753A/T1768A联合突变后的核心启动子(CM—HBX),再以慢病毒感染的方式构建稳定表达核心启动子的L-02细胞株,建立肝癌发生的细胞模型。方法通过基因合成的方法,合成A1762rr/G1764A/T1753A/T1768A联合突变后的核心启动子,在N末端加上标记序列HBX—Flag,分别双酶切pLenO—RTP载体和pUC57-CM—HBX,纯化酶切产物后进行定向连接,得到重组质粒pLenO-RTP—CM—HBX。钙转法将重组质粒转入293T细胞进行病毒包装然后转染肝细胞。噻唑蓝(Mr丌)比色法检测转染后细胞增殖能力的变化,Westernblot法检测HBX—Flag在慢病毒感染后L-02中的表达以及转染后细胞内s期激酶相关蛋白2(Skp2)、增殖细胞核抗原(PCNA)、p21、p53的表达的变化。结果构建pLenO。RTP—CM—HBX核心启动子慢病毒载体可以效率较高地感染L-02(〉95%),并在细胞内转录、翻译、合成HBX—Flag,随着培养时间的延长,红色荧光强度无明显变化;同空载组和空白对照组比较,联合突变组L-02的增殖能力明显增强(P〈0.05),skp2、PCNA表达增加,p21、p53表达降低(P〈0.05)。而空载组和空白对照组的各指标差异无统计学意义(P〉0.05)。结论慢病毒载体pLenO—RTP.CM—HBX核心启动子成功转染L-02,转染后的L-02具有癌变倾向。 Objective The core promoter (CP) region overlaps with the hepatitis B virus (HBV) X gene. Clinical research has shown that A1762T/G1764A (TA)/T1753A/T1768A mutation in overlapping sequence can increase risk of hepatocellular carcinoma (HCC). In order to establish a kind of cell model of hepatocarcinogenesis, we construct A1762T/G1764A/T1753A/T1768A combo mutant core promoter through the gene synthesis, and then infect the cell L-02. Methods In order to obtain recombinant plas-mid pLenO-RTP-CM-HBX, the pLenO-RTP carrier and pUC57-CM-HBX were connected directly after double restriction enzyme digestion. The recombinant plasmid was transfected into 293 T cells for virus packaging through Calcium turn method, and then L-02 cells were infected. The change of proliferation ability after transfection was detected through methyl thiazol tetrazolium (MTT) method. HBX-Flag, S- phase kinase-associated protein-2 (Skp2), proliferating cell nuclear antigen (PCNA), p21 and p53 ex- pression changes were detected by using Western blotting. Results The pLenO-RTP-CM-HBX core pro- moter lentivirus carrier could infect L-02 cells with high efficiency ( 〉 95% ) , and then HBX-Flag was transcribed, translated, synthetized and secreted in L-02 cells after transfection. The red fluorescence in- tensity did not change obviously with the extension of incubation time. The proliferation ability, and Skp2 and PCNA expression of cells in combo mutant group was increased, and p21 and p53 expression was re- duced compared to light group and blank control group ( P 〈 0. 05 ). There was no significant difference be- tween light group and blank control group. Conclusion The pLenO-RTP-CM-HBX core promoter lentivirus carrier was transfected into Ll02 cells successfully, and the L-02 ceils after transfection had tendency to be- come cancerous.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第6期1224-1227,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(81000177) 教育部博士点基金新教师类资助项目(20110171120090) 2013年广州市科技计划资助项目
关键词 核心启动子 乙肝病毒 慢病毒载体 联合突变 Core promoter Hepatitis B virus Lentivirus carrier Combo mutation
  • 相关文献

参考文献10

  • 1Huang Y, Tong S, Tai AW, et al. Hepatitis B virus core promoter mu- tations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21. Gastroenterology,2011,141 : 1412-1421.
  • 2高学松,成军,甄真,郭江,张黎颖.乙型肝炎核心启动子的研究进展[J].世界华人消化杂志,2005,13(8):933-936. 被引量:5
  • 3Kuang SY, Jackson PE, Wang JB, et al. Spedfic mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A,2004,101:3575-3580.
  • 4Huy T'F, Ushijima H, Quang VX, et al. Characteristics of core promot- er and precore stop codon mutants of hepatitis B virus in Vietnam. J Med Viro1,2004 ,74 :228-236.
  • 5Yuen MF, Tanaka Y, Mizokami M, et al. Role of hepatitis B virus gen- otypes Ba and C, core promoter mutations on hepatocellular carcino- ma : a case control study. Carcinogenesis ,2004 ,25 : 1593-1598.
  • 6Yang HI,Lu SN,Liaw YF,et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med,2002,347:168-174.
  • 7Chen C J, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. J~MA, 2006,295:65-73.
  • 8陈谦学,郑虎,刘刚,吴立权,王军民.Skp2、PTEN和p27在胶质瘤中的表达及其意义[J].中华实验外科杂志,2006,23(7):864-866. 被引量:16
  • 9Bartek J, Lukas J. DNA damage checkpoints:from initiation to recov- ery or adaptation. Curt Opin Cell Bio!,2007,19:238-245.
  • 10Prost S, Ford JM, Taylor C, et al. Hepatitis B X protein inhibits p53- dependent DNA repair in primary mouse hepatocytes. J Biol Chem, 1998,273:33327-33332.

二级参考文献47

  • 1杨艳杰,成军,陈东风,王春花,黄燕萍,吴煜,刘敏,王建军,钟彦伟,刘妍,张黎颖.应用噬菌体展示技术筛选HBsAg启动子I的DNA结合蛋白[J].世界华人消化杂志,2004,12(11):2737-2739. 被引量:4
  • 2骆抗先.乙型肝炎基础和临床(第2版)[M].北京:人民卫生出版社,2001.415-435.
  • 3Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M,Moriyama K, Tanaka T, Miyakawa Y, Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994,68:8102-8110.
  • 4Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.J Virol 1996,70:5845-5851.
  • 5Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N,Trepo C, Wands J, Tong S. Genome replication, virion secretion,and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 2003,77:6601-6612.
  • 6Ogata N, Miller RH, Ishak KG, Purcell RH. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 1993,194:263-276.
  • 7Hasegawa K, Huang J, RogersSA, Blum HE, Liang TJ. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994,68:1651-1659.
  • 8Alexopoulou A, Karayiannis P, Hadziyannis SJ, Hou J,Pickering J, Luo K, Thomas HC. Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis:genetic variability and its potential role in disease pathogenicity.I Viral He,at 1996,3:173-181.
  • 9Gerner P, Lausch E, Friedt M, Tratzmuller R, Spangenberg C,Wirth S. Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity. J Med Virol 1999,59:415-423.
  • 10Scaglioni PP, Melegari M, Wands JR. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 1997,233:374-381.

共引文献19

同被引文献5

  • 1Chau DK,Chen GG,Zhang H,et al. Differential functions of C-and N- terminal hepatitis B x protein in liver ceils treated with doxorubicin in normoxic or hypoxic condition [ J ]. PLoS One,2012,7 ( 11 ) : e50118.
  • 2Huang Y, Tai AW, Tong S, et al. HBV core promoter mutations pro- mote cellular proliferation through E2Fl-mediated upregulation of S- phase kinase-associated protein 2 transcription [ J ]. J Hepatol, 2013, 58(6) :1068-1073.
  • 3Nordenstedt H, White DL, E1-Serag HB. The changing pattern of epi- demiology in hepatocellular carcinoma [ J]. Dig Liver Dis, 2010,42 Suppl 3 : $206-$214.
  • 4Motavaf M, Safari S, Saffari JM, et al. Hepatitis B virus-induced hepa- tocellular carcinoma :the role of the virus x protein [ J ]. Acta Virol, 2013,57 (4) :389-396.
  • 5周源,凌贤龙.人肝癌顺铂耐药细胞系SK-Hep1/CDDP的建立[J].癌症,2010,29(2):176-181. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部